These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12756800)
1. Immunological characterisation of sub-units of the Yersinia type III secretion apparatus. Hill J; Underwood CD; Sundberg L; Aström H; Leary SE; Forsberg A; Titball RW Adv Exp Med Biol; 2003; 529():415-7. PubMed ID: 12756800 [No Abstract] [Full Text] [Related]
2. Construction of defined F1 negative mutants of virulent Yersinia pestis. Worsham PL; Stein MP; Welkos SL Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864 [No Abstract] [Full Text] [Related]
3. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Friedlander AM; Welkos SL; Worsham PL; Andrews GP; Heath DG; Anderson GW; Pitt ML; Estep J; Davis K Clin Infect Dis; 1995 Oct; 21 Suppl 2():S178-81. PubMed ID: 8845449 [TBL] [Abstract][Full Text] [Related]
4. Live-attenuated Yersinia pestis vaccines. Wang X; Zhang X; Zhou D; Yang R Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796 [TBL] [Abstract][Full Text] [Related]
5. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague. Leary SE; Eley SM; Williamson ED; Titball RW Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838 [No Abstract] [Full Text] [Related]
6. A plague upon the phagocytes. DeLeo FR; Hinnebusch BJ Nat Med; 2005 Sep; 11(9):927-8. PubMed ID: 16145573 [No Abstract] [Full Text] [Related]
7. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474 [TBL] [Abstract][Full Text] [Related]
8. Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague. Grosfeld H; Bino T; Flashner Y; Ber R; Mamroud E; Lustig S; Velan B; Shafferman A; Cohen S Adv Exp Med Biol; 2003; 529():423-4. PubMed ID: 12756802 [No Abstract] [Full Text] [Related]
9. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice. Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022 [TBL] [Abstract][Full Text] [Related]
10. [A molecular basis of the plague vaccine development]. Dentovskaia SV; Kopylov PKh; Ivanov SA; Ageev SA; Anisimov AP Mol Gen Mikrobiol Virusol; 2013; (3):3-12. PubMed ID: 24364139 [TBL] [Abstract][Full Text] [Related]
11. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens]. Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769 [No Abstract] [Full Text] [Related]
15. Large-scale purification of the F1 antigen of Yersinia pestis. Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865 [No Abstract] [Full Text] [Related]
16. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague. Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198 [TBL] [Abstract][Full Text] [Related]